Viewing Study NCT04152434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-28 @ 3:47 AM
Study NCT ID: NCT04152434
Status: COMPLETED
Last Update Posted: 2019-11-05
First Post: 2019-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy
Sponsor: Clinique des Céphalées de Montréal
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Chronic Migraine View
Keywords: